跳至主要内容
临床试验/EUCTR2009-010966-47-DE
EUCTR2009-010966-47-DE进行中(未招募)不适用

Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients With SchizophreniaThe Neuroleptic Strategy Study - NeSSy - NeSSy

niversität Bremen0 个研究点开始时间: 2009年10月14日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Key inclusion criteria:
  • Patients with schizophrenia, age 18-65, necessity to establish new or change antipsychotic treatment due to unsatisfying results or side effects.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 630
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Key exclusion criteria:
  • Acute suicidal tendency, Einwilligungsvorbehalt (BGB)” or Unterbringung (PsychKG), organic psychosis, history of malignant neuroleptic syndrome, QTc interval = 0.5s / history of congenital QTc prolongation.

研究者

发起方
niversität Bremen

相似试验